論文

査読有り
2017年5月

Low-Intensity Training and the C5a Complement Antagonist NOX-D21 Rescue the mdx Phenotype through Modulation of Inflammation

AMERICAN JOURNAL OF PATHOLOGY
  • Janek Hyzewicz
  • ,
  • Jun Tanihata
  • ,
  • Mutsuki Kuraoka
  • ,
  • Yuko Nitahara-Kasahara
  • ,
  • Teiva Beylier
  • ,
  • Urs T. Ruegg
  • ,
  • Axel Vater
  • ,
  • Shin'ichi Takeda

187
5
開始ページ
1147
終了ページ
1161
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1016/j.ajpath.2016.12.019
出版者・発行元
ELSEVIER SCIENCE INC

Inflammatory events occurring in dystrophic muscles contribute to the progression of Duchenne muscular dystrophy (DMD). Low-intensity training (LIT) attenuates the phenotype of mdx mice, an animal model for DMD. Therefore, we postulated that LIT could have anti-inflammatory properties. We assessed levels of inflammatory cytokines and infiltrated immune cells in gastrocnemius muscle of mdx mice after LIT. We detected high levels of complement component C5a, chemokine ligand (CCL) 2, CD68(+) monocytes/macrophages, and proinflammatory M1 macrophages in muscles of mdx mice. LIT decreased CCL2 levels, increased CD68(+) cell numbers, and shifted the macrophage population to the regenerative M2 type. We investigated whether inhibition of C5a or CCL2 with L-aptamers could mimic the effects of LIT. Although no effect of CCL2 inhibition was detected, treatment with the C5a inhibitor, NOX-D21, rescued the phenotype of nonexercised mdx mice, but not of exercised ones. In both cases, the level of CD68(+) cells increased and macrophage populations leaned toward the inflammatory M1 type. In muscles of nonexercised treated mice, the level of IL-1 receptor antagonist increased, damage decreased, and fibers were switched toward the glycolytic fast type; in muscles of exercised mice, fibers were switched to the oxidative slow type. These results reveal the effects of LIT on the inflammatory status of mdx mice and suggest that NOX-D21 could be an anti-inflammatory drug for DMD.

リンク情報
DOI
https://doi.org/10.1016/j.ajpath.2016.12.019
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/28315675
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000400229600017&DestApp=WOS_CPL
ID情報
  • DOI : 10.1016/j.ajpath.2016.12.019
  • ISSN : 0002-9440
  • eISSN : 1525-2191
  • PubMed ID : 28315675
  • Web of Science ID : WOS:000400229600017

エクスポート
BibTeX RIS